Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- James I Geller
Children's Oncology Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
69 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Children'S Hospital of Alabama
Birmingham, Alabama, United States
- Arkansas Children'S Hospital
Little Rock, Arkansas, United States
- Kaiser Permanente Downey Medical Center
Downey, California, United States
- Loma Linda University Medical Center
Loma Linda, California, United States
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Children'S Hospital and Research Center at Oakland
Oakland, California, United States
- Children'S Hospital of Orange County
Orange, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- Rady Children'S Hospital - San Diego
San Diego, California, United States
- Ucsf Medical Center-Mission Bay
San Francisco, California, United States
- Children'S Hospital Colorado
Aurora, Colorado, United States
- Yale University
New Haven, Connecticut, United States
- Alfred I Dupont Hospital for Children
Wilmington, Delaware, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- Golisano Children'S Hospital of Southwest Florida
Fort Myers, Florida, United States
- Nicklaus Children'S Hospital
Miami, Florida, United States
- Adventhealth Orlando
Orlando, Florida, United States
- Johns Hopkins All Children'S Hospital
St. Petersburg, Florida, United States
- Children'S Healthcare of Atlanta - Egleston
Atlanta, Georgia, United States
- Kapiolani Medical Center for Women and Children
Honolulu, Hawaii, United States
- Saint Luke'S Mountain States Tumor Institute
Boise, Idaho, United States
- Lurie Children'S Hospital-Chicago
Chicago, Illinois, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- Saint Jude Midwest Affiliate
Peoria, Illinois, United States
- Riley Hospital for Children
Indianapolis, Indiana, United States
- Saint Vincent Hospital and Health Care Center
Indianapolis, Indiana, United States
- University of Kentucky/markey Cancer Center
Lexington, Kentucky, United States
- Ochsner Medical Center Jefferson
New Orleans, Louisiana, United States
- Eastern Maine Medical Center
Bangor, Maine, United States
- Maine Children'S Cancer Program
Scarborough, Maine, United States
- Johns Hopkins University/sidney Kimmel Cancer Center
Baltimore, Maryland, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- C S Mott Children'S Hospital
Ann Arbor, Michigan, United States
- Ascension Saint John Hospital
Detroit, Michigan, United States
- Wayne State University/karmanos Cancer Institute
Detroit, Michigan, United States
- Helen Devos Children'S Hospital at Spectrum Health
Grand Rapids, Michigan, United States
- Children'S Hospitals and Clinics of Minnesota - Minneapolis
Minneapolis, Minnesota, United States
- University of Minnesota/masonic Cancer Center
Minneapolis, Minnesota, United States
- Mayo Clinic
Rochester, Minnesota, United States
- University of Mississippi Medical Center
Jackson, Mississippi, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Oct 2015
- Primary completion
- 30 Jun 2017
- Completion
- 30 Sept 2021
- Last update posted
- 13 Jan 2022
- Registered enrollment
- 62
- Registry id
- NCT02452554
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.